Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Select Advanced Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT03127215
What this trial is testing

Study of Olaparib/Trabectedin vs. Doctor's Choice in Solid Tumors

Who this might be right for
Cancers With DNA Repair-Deficiency
National Center for Tumor Diseases, Heidelberg 102
Early research (Phase 1)UnknownNCT06199908
What this trial is testing

AMT-562 in Patients With Selected Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Multitude Therapeutics (Australia) Pty Ltd 72
Not applicableNot Yet RecruitingNCT07831148
What this trial is testing

Music Therapy Program for Patients in Palliative Care (MUSPAL360)

Who this might be right for
CancerPalliative Care
Austral University, Argentina 40
Early research (Phase 1)Ended earlyNCT06877533
What this trial is testing

A First-in-Human Open-label, Phase I/Ib Dose Escalation and Expansion Cohort Study of EOS006215 as Monotherapy and in Combination With Pembrolizumab or Other Anticancer Treatments in Participants With Advanced Solid Tumors

Who this might be right for
Selected Advanced Solid Tumors
iTeos Belgium SA 3
Testing effectiveness (Phase 2)Study completedNCT02327078
What this trial is testing

The Safety, Tolerability, and Efficacy of Epacadostat Administered in Combination With Nivolumab in Select Advanced Cancers (ECHO-204)

Who this might be right for
B-cell MalignanciesColorectal Cancer (CRC)Head and Neck Cancer+5 more
Incyte Corporation 307
Testing effectiveness (Phase 2)Study completedNCT02675231
What this trial is testing

Abemaciclib (LY2835219) in Women With HR+, HER2+ Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Hormone Receptor Positive Breast CancerHER-2 Positive Breast Cancer
Eli Lilly and Company 237
Testing effectiveness (Phase 2)UnknownNCT05399654
What this trial is testing

A Dose Escalation and Expansion Study of TAC-001 in Patients With Select Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Tallac Therapeutics 72
Testing effectiveness (Phase 2)UnknownNCT04092673
What this trial is testing

Study of eFT226 in Subjects With Selected Advanced Solid Tumor Malignancies

Who this might be right for
Solid Tumor, Adult
Effector Therapeutics 30
Early research (Phase 1)Study completedNCT02049593
What this trial is testing

PARP Inhibitor BMN-673 and Temozolomide or Irinotecan Hydrochloride in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Metastatic CancerUnspecified Adult Solid Tumor
Jonsson Comprehensive Cancer Center 44
Testing effectiveness (Phase 2)UnknownNCT05453825
What this trial is testing

Navicixizumab Monotherapy or in Combination in Patients With Select Advanced Solid Tumors

Who this might be right for
Colorectal CancerTriple Negative Breast CancerGastric Cancer+1 more
OncXerna Theraputics, Inc. 180
Post-approval studies (Phase 4)UnknownNCT05809024
What this trial is testing

Select the Appropriate Population for Adding CDK4/6i to Neoadjuvant Endocrine Therapy

Who this might be right for
Locally Advanced Breast CancerHormone Receptor Positive，HER2-negative Breast Cancer
Yongsheng Wang 100
Large-scale testing (Phase 3)Looking for participantsNCT07197580
What this trial is testing

Phase 3 Study to Assess Safety and Efficacy of 177Lu-TLX250 in Advanced Relapsed or Recurrent ccRCC

Who this might be right for
ccRCCRenal Cell Carcinoma (Kidney Cancer)Renal Cell Carcinoma (RCC)+3 more
Telix Pharmaceuticals (Innovations) Pty Limited 40
Testing effectiveness (Phase 2)Study completedNCT05597839
What this trial is testing

Study of DF9001 in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor, Adult
Dragonfly Therapeutics 24
Testing effectiveness (Phase 2)UnknownNCT03997539
What this trial is testing

Pyrotinib Plus Vinorelbine in Comparison With Treatment of Physician's Choice in Participants With HER2-positive Locally Advanced or Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Sun Yat-sen University 256
Early research (Phase 1)Study completedNCT04972981
What this trial is testing

Evaluate the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of ADCT-901 in Participants With Selected Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
ADC Therapeutics S.A. 30
Early research (Phase 1)Study completedNCT02054806
What this trial is testing

Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-028/KEYNOTE-28)

Who this might be right for
Solid Tumor
Merck Sharp & Dohme LLC 477
Large-scale testing (Phase 3)Looking for participantsNCT06312176
What this trial is testing

Sacituzumab Tirumotecan (MK-2870) as a Single Agent and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With HR+/HER2- Unresectable Locally Advanced or Metastatic Breast Cancer (MK-2870-010)

Who this might be right for
Breast Neoplasms
Merck Sharp & Dohme LLC 1,200
Testing effectiveness (Phase 2)Study completedNCT05512377
What this trial is testing

Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

Who this might be right for
Pancreatic NeoplasmsSolid TumorsBiliary Tract Cancer+2 more
Boehringer Ingelheim 99
Testing effectiveness (Phase 2)Ended earlyNCT04916002
What this trial is testing

A Trial To Find Out If Vidutolimod Together With Cemiplimab Is Safe And If It Works In Adult Participants With Advanced Cancer Or Metastatic Cancer

Who this might be right for
Merkel Cell CarcinomaCutaneous Squamous Cell CarcinomaBasal Cell Carcinoma+3 more
Regeneron Pharmaceuticals 77
Early research (Phase 1)Looking for participantsNCT07454642
What this trial is testing

AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors

Who this might be right for
Vulvar AdenocarcinomaPDAC - Pancreatic Ductal AdenocarcinomaGastric Adenocarcinoma+6 more
Avacta Life Sciences Ltd 174
Next Page